GENEVA — The World Health Organisation said Friday it"strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
For the same patients, the WHO also made a"conditional recommendation" of the antiviral drug remdesivir made by US biotech firm Gilead — which it had previously recommended against. The new recommendation was based on the findings of two trials involving almost 3,100 patients which showed that Paxlovid reduced the risk of hospital admission by 85 per cent.
This means the patients must quickly test positive and be prescribed the pill by a doctor — all of which can pose obstacles for low- and middle-income countries, the WHO said. Remdesivir can be taken within seven days of symptoms setting in, but it is administered intravenously over three days.The WHO called on Pfizer to"make its pricing and deals more transparent" for Paxlovid.
When does the indoor mask rule get relaxed?
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Clinical trial under way in S'pore on use of Lianhua Qingwen TCM pill for Covid-19 treatment以前觉得连花清瘟就是坑钱的，后来出了vds打针胁迫计划，发现我还是太年轻了。那些个不防传染的mrna“新技术”逼着人干才是真狠，看似免费，同样套财政的钱每针估计比每盒连花清瘟要高太多了，还直接做了针剂试验。 I bought that from Chinese herbal shop in London pre covid as recommended for flu and it works for flu, I never got covid. But you can only use for five days as rough on liver herbalist said.
Source: straits_times - 🏆 5. / 69 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »